share_log

Intra-Cellular Therapies Price Target Cut to $74.00/Share From $77.00 by Goldman Sachs

Intra-Cellular Therapies Price Target Cut to $74.00/Share From $77.00 by Goldman Sachs

高盛将Intra-Cellular Therapies的股票价格目标下调至74.00美元/股,之前为77.00美元。
道琼斯 ·  08/08 08:17  · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发